Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Directly Acting Antivirals”

179 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 179 results

Not applicableUnknownNCT03820102
What this trial is testing

Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs

Who this might be right for
HCV
Assiut University 100
Not applicableStudy completedNCT04330508
What this trial is testing

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial

Who this might be right for
Depression in Chronic Hepatitis C
Post Graduate Institute of Medical Education and Research, Chandigarh 385
Not applicableUnknownNCT03687229
What this trial is testing

The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV Patients

Who this might be right for
Chronic Hepatitis c
Assiut University 60
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Post-approval studies (Phase 4)Active Not RecruitingNCT03520660
What this trial is testing

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Who this might be right for
Diabetes MellitusHepatitis C, ChronicCardiovascular Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 121
Not applicableNot Yet RecruitingNCT07097870
What this trial is testing

Predictors of HCC in Post-HCV Cirrhotic Patients After SVR

Who this might be right for
HCC - Hepatocellular Carcinoma
Sohag University 400
Not applicableStudy completedNCT03612973
What this trial is testing

Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy

Who this might be right for
Chronic Hepatitis c
Assiut University 80
Post-approval studies (Phase 4)Study completedNCT02156570
What this trial is testing

DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)

Who this might be right for
Hepatitis C
Kirby Institute 20
Large-scale testing (Phase 3)Study completedNCT02822794
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 117
Testing effectiveness (Phase 2)Study completedNCT02583685
What this trial is testing

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 138
Testing effectiveness (Phase 2)Study completedNCT02413593
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Not applicableStudy completedNCT03248622
What this trial is testing

Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection

Who this might be right for
Hepatitis B
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 79
Large-scale testing (Phase 3)Study completedNCT02399345
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

Who this might be right for
Chronic Hepatitis C Virus (HCV Infection Genotype 1)
AbbVie 10
Not applicableEnded earlyNCT02510300
What this trial is testing

A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 461
Not applicableUnknownNCT04039698
What this trial is testing

Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil

Who this might be right for
Chronic Hepatitis C
Hospital de Clinicas de Porto Alegre 144
Not applicableStudy completedNCT06829966
What this trial is testing

Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver Diseases

Who this might be right for
Intestinal Microbiota Between Different Groups
Assiut University 30
Not applicableStudy completedNCT03740906
What this trial is testing

Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 202
Testing effectiveness (Phase 2)Study completedNCT02536313
What this trial is testing

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 49
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Post-approval studies (Phase 4)Study completedNCT02938013
What this trial is testing

DeLIVER: Direct Acting Antiviral Effects on the Liver

Who this might be right for
HCV CoinfectionLiver DiseaseHIV
Johns Hopkins University 15
Load More Results